Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIV.
Liu WD, Lin MS, Sun HY, Shih MC, Chuang YC, Huang YS, Lin KY, Li GC, Wu PY, Chen LY, Liu WC, Su YC, He PC, Chen YT, Lin CY, Cheng YC, Yao Y, Yeh YC, Liu CC, Pan MY, Luo YZ, Chang HY, Wang JT, Sheng WH, Hsieh SM, Chang SY, Hung CC.
Liu WD, et al.
J Microbiol Immunol Infect. 2024 Feb 26:S1684-1182(24)00041-0. doi: 10.1016/j.jmii.2024.02.004. Online ahead of print.
J Microbiol Immunol Infect. 2024.
PMID: 38429206
Free article.
RESULTS: Of 1427 participants undergoing the third-dose COVID-19 vaccination, 632 (44.3%) received 100-mug mRNA-1273, 467 (32.8%) 50-mug mRNA-1273, and 328 (23.0%) BNT162b2 vaccine and the respective rate of SARS-CoV-2 infection or seroconversion of anti-nucleocapsid IgG was 246. …
RESULTS: Of 1427 participants undergoing the third-dose COVID-19 vaccination, 632 (44.3%) received 100-mug mRNA-1273, 467 (32.8%) 50-mug mRN …